News in other languages: Amoéba

10-02	Amoéba : Amoéba organise un webinaire le 7 octobre 2026 à 18h00 pour présenter son augmentation de capital ouverte à tous
10-02	Amoéba : Amoéba veut associer ses actionnaires à sa dernière levée de fonds, avant la monétisation de sa plateforme cosmétique, pour financer son démarrage commercial
09-25	Bourse : les Arnault à la Maison Blanche, HelloFresh avertit et Meta 2000
09-25	Amoéba : Amoéba annonce le succès de la première partie de sa levée de fonds destinée à atteindre l’autonomie financière
09-25	Le Nasdaq tient tête à l'obligataire

More news

Managers and Directors: Amoéba

Manager	Title	Age	Since
Dominique Jean Francois Marie Doucet CEO	Chief Executive Officer	60	13/12/2023
Sandrine Troussieux CTO	Chief Tech/Sci/R&D Officer	-	31/08/2018
Jean-Baptiste Eberst LAW	General Counsel	-	30/06/2015

Director	Title	Age	Since
Valérie Filiatre BRD	Director/Board Member	-	31/05/2014
Benoît Villers CHM	Chairman	70	13/12/2023
Jean-luc Souche BRD	Director/Board Member	70	24/05/2023

More insiders

Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.

Employees

Sector

Agricultural Chemicals

More about the company

Quotes

Date	Price	Change	Volume
12/10/26	€0.3260	+10.70%	1,593,121
09/10/26	€0.2945	+0.86%	269,587
08/10/26	€0.2920	-5.35%	489,436
07/10/26	€0.3085	-2.37%	298,757
06/10/26	€0.3160	-4.24%	437,846

Real-time Euronext Paris

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.3260EUR

Average target price

1.000EUR

Spread / Average Target

+206.75%

Consensus

EPS Estimates

Evolution of Analysts' Estimates - EPS - Amoéba

Revisions to estimates

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Amoéba

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris 16:55:00 12/10/2026 BST			5-day change	1st Jan Change
0.3260 ^EUR	+10.70%		-1.21%	-69.19%

09-23	Amoéba S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-09	Amoéba, Syngenta Sign European Distribution Deal for Biocontrol Fungicide	MT

Market Cap	22.46M 25.09M 20.93M 18.99M 35.81M 2.4B 36.04M 252M 98.48M 1.24B 94.23M 92.15M 3.98B	P/E 2026 *	-4.35x	P/E 2027 *	32.6x
Enterprise Value	33.61M 37.54M 31.33M 28.42M 53.6M 3.59B 53.93M 376M 147M 1.85B 141M 138M 5.96B	EV / Sales 2026 *	6.59x	EV / Sales 2027 *	2.21x
Free-Float	81.63%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Euronext Paris	ALMIB	Real-time
Börse Stuttgart	A1H	Delayed
Deutsche Boerse AG	A1H	Delayed
Boerse Muenchen	A1H	Real-time

09-23	Amoéba S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-09	Amoéba, Syngenta Sign European Distribution Deal for Biocontrol Fungicide	MT
07-23	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
07-01	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI
06-30	Amoéba gains from marketing authorization in France
06-30	Amoéba Bags Marketing Approval for Biofungicide in France	MT
06-30	Amoéba wins marketing authorization in France
06-08	Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy	CI
06-08	Amoéba secures strategic emergency authorization in Italy
05-06	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI
04-28	Amoéba Announces Emergency Authorization for Axpera Biocontrol Solution	CI
04-28	Amoéba secures emergency authorization for downy mildew treatment in France
04-13	Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops	CI

Amoéba Share Price

Stocks

ALMIB

FR0011051598

Agricultural Chemicals

Valuation: Amoéba

Chart: Amoéba

Latest news: Amoéba

Press Releases: Amoéba

News in other languages: Amoéba

Quotes and Performance

Price Extremes

Managers and Directors: Amoéba

Latest insider transactions

Pesticide

Financials

Company Profile

Quotes

Analysts' Consensus

Annual profits - Rate of surprise

10-02	Amoéba : Amoéba aims to involve its shareholders in its latest fundraising round, ahead of the monetisation of its cosmetics platform, to finance its commercial launch	AT
09-25	Amoéba : Amoéba announces the success of the first phase of its fundraising campaign aimed at achieving financial self-sufficiency	AT
09-24	Amoéba : Amoéba launches a two-phase capital increase expected to be its final market financing before achieving financial self-sufficiency	AT
09-24	Amoéba : Amoéba becomes an industrial and commercial company in biocontrol and initiates a process to monetize its cosmetics asset	AT
09-10	Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers	GL

1 day	+10.70%
1 week	-1.21%
Current month	+2.84%
1 month	-43.50%
3 months	-56.99%
6 months	-63.08%
Current year	-69.19%

1 week	0.28	0.35
1 month	0.28	0.56
Current year	0.28	1.12
1 year	0.28	1.2
3 years	0.28	1.44
5 years	0.28	1.8
10 years	0.28	34.93

Date	Insider	Type	Main position	Quantity	% Market Cap.
30/06/26	Benoît Villers	Sell	Chairman	-31,100	0.0400%
23/05/25	Dominique Jean Francois Marie Doucet	Exercice	Chief Executive Officer	40,000	0.0805%
22/05/25	Dominique Jean Francois Marie Doucet	Exercice	Chief Executive Officer	560,000	1.1277%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOÉBA	+10.70%	-1.21%	-68.04%	-19.31%	25.09M
NUTRIEN LTD.	-3.21%	-3.77%	+14.90%	+17.52%	32.2B
QINGHAI SALT LAKE INDUSTRY CO.,LTD	-2.70%	-1.64%	+6.59%	+32.28%	18.53B
CF INDUSTRIES HOLDINGS, INC.	+2.73%	-1.24%	+31.19%	+34.74%	17.34B
SABIC AGRI-NUTRIENTS COMPANY	-2.04%	-2.37%	-3.92%	-13.96%	14.61B
PHOSAGRO	+0.11%	-.--%	-.--%	-.--%	12.96B
YARA INTERNATIONAL ASA	-3.19%	-3.21%	+6.83%	+0.43%	10.66B
JORDAN PHOSPHATE MINES CO. PLC	+1.20%	-5.18%	+18.35%	+177.45%	10.72B
CORTEVA, INC.	+0.45%	+7.34%	-	-	8.87B
ACRON	-0.22%	-.--%	-.--%	-.--%	8.3B
Average	+0.38%	-0.90%	+0.66%	+25.46%	13.42B
Weighted average by Cap.	-1.14%	-1.50%	+10.80%	+27.66%

	2026 *	2027 *
Net sales	5.1M 5.7M 4.75M 4.31M 8.13M 545M 8.18M 57.13M 22.37M 281M 21.4M 20.93M 904M	15.55M 17.37M 14.5M 13.15M 24.8M 1.66B 24.95M 174M 68.19M 857M 65.25M 63.81M 2.76B
Net income	-5.2M -5.81M -4.85M -4.4M -8.29M -555M -8.34M -58.25M -22.8M -287M -21.82M -21.34M -922M	550K 614K 513K 465K 877K 58.73M 883K 6.16M 2.41M 30.31M 2.31M 2.26M 97.53M
Net Debt	11.15M 12.46M 10.39M 9.43M 17.78M 1.19B 17.89M 125M 48.9M 614M 46.79M 45.75M 1.98B	11.85M 13.24M 11.05M 10.02M 18.9M 1.27B 19.02M 133M 51.97M 653M 49.72M 48.62M 2.1B